The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies.
 
Rachel N. Grisham
No Relationships to Disclose
 
Dilip D. Giri
No Relationships to Disclose
 
Alexia Iasonos
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Jeffrey Girshman
No Relationships to Disclose
 
Sean Patrick McGrath
No Relationships to Disclose
 
Roisin Eilish O'Cearbhaill
No Relationships to Disclose
 
Paul Sabbatini
Research Funding - Bristol-Myers Squibb (Inst); Ludwig Institute for Cancer Research (Inst)
 
William P. Tew
No Relationships to Disclose
 
David Michael Hyman
Consulting or Advisory Role - Atara Biotherapeutics; Chugai Pharma; CytomX Therapeutics
Research Funding - AstraZeneca; Puma Biotechnology
 
Martee Leigh Hensley
Employment - Sanofi (I)
Consulting or Advisory Role - EMD Serono; Janssen; Tesaro
Research Funding - Johnson & Johnson (Inst)
Patents, Royalties, Other Intellectual Property - author, Up to Date
 
Dmitriy Zamarin
Employment - Acorda Therapeutics (I)
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - I hold a patent regarding the use of recombinant Newcastle Disease Virus (NDV) for cancer therapy. (Inst)
Travel, Accommodations, Expenses - Targovax
 
Jason A. Konner
Consulting or Advisory Role - Clovis Oncology; Genentech/Roche
Research Funding - AstraZeneca/MedImmune; Genentech/Roche; TapImmune Inc.
 
Alexandra Snyder Charen
Consulting or Advisory Role - Driver Group; Third Rock Ventures
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche
 
Karen Anne Cadoo
Research Funding - AstraZeneca (Inst)
 
David R. Spriggs
Patents, Royalties, Other Intellectual Property - Through my laboratory, we haver discovered anti-MUC16 antibodies that MSKCC has filed patents about. These patents, if commercialized could ultimately result in royalties paid to me. (Inst)
 
Gopa Iyer
No Relationships to Disclose
 
Carol Aghajanian
Consulting or Advisory Role - Bayer; Cerulean Pharma; Cerulean Pharma; Oxigene; VentiRx